TCRG on OTC
Cannaisseur Group Inc.
Price unavailable
Last updated Oct 16, 2026.
Overview
Compare with AIBOTICS, INC., NEUTRA CORP. or NUTRA PHARMA CORP, or pick any stock.
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
-100.0%Revenue growth, 20253
Financial statements
Every line of the income statement in the latest annual report, as filed.3
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Revenue, net of discounts | $0 | $700 |
| Cost of revenue | $910 | $4.3K |
| Gross profit | -$910 | -$3.6K |
| Selling, general and administrative expenses | $1.7M | $1.3M |
| Total operating expenses | $1.7M | $1.3M |
| Operating loss | -$1.7M | -$1.3M |
| Gain on settlement of accounts payable | $3.8K | $0 |
| Loss on conversion of related party debt | -$23.3K | $0 |
| Loss on settlement of mezzanine equity | -$68.2K | $0 |
| Interest expense | -$4.3K | -$6.4K |
| Total other income (expense) | -$91.9K | -$6.4K |
| Net loss before taxes | -$1.8M | -$1.3M |
| Income tax benefit | $0 | $0 |
| Net loss | -$1.8M | -$1.3M |
| Less: Net loss attributable to minority interest | -$34.5K | -$3.6K |
| Net loss attributable to TCGI | -$1.8M | -$1.3M |
| Basic (in Shares) | 53.9M shares | 43.8M shares |
| Diluted (in Shares) | 53.9M shares | 43.8M shares |
| Basic (in Dollars per share) | -$0.03 | -$0.03 |
| Diluted (in Dollars per share) | -$0.03 | -$0.03 |
Every line of the balance sheet in the latest annual report, as filed.3
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash | $22 | $563 | |
| Accounts receivable | $0 | $285 | |
| Inventory | $118 | $1.0K | |
| Total current assets | $140 | $1.9K | |
| TOTAL ASSETS | $140 | $1.9K | |
| Accounts payable and accrued expenses | $192.2K | $169.8K | |
| Settlement payable | $9.5K | $9.5K | |
| Notes payable, current portion | $7.4K | $6.7K | |
| Dividends payable | $1.6K | $1.6K | |
| Total current liabilities | $210.6K | $229.1K | |
| Long term notes payable, non current portion | $24.8K | $25.5K | |
| Total long term liabilities | $24.8K | $76.5K | |
| TOTAL LIABILITIES | $235.4K | $305.6K | |
| Mezzanine Equity | $0 | $37.9K | |
| Common stock, $0.0001 par value, 500,000,000 shares authorized, 60,459,890 and 44,337,557 shares issued and outstanding as of December 31, 2025 and 2024, respectively | $6.0K | $4.4K | |
| Additional paid in capital | $3.4M | $1.5M | |
| Accumulated deficit | -$3.5M | -$1.7M | |
| Minority interest | -$142.4K | -$107.9K | |
| Total Stockholders Deficit | -$235.3K | -$341.6K | -$130.9K |
| TOTAL LIABILITIES AND STOCKHOLDERS DEFICIT | $140 | $1.9K | |
| Common Stock, par value (in Dollars per share) | $0.00 | $0.00 | |
| Common Stock, shares authorized (in Shares) | 500.0M shares | 500.0M shares | |
| Common Stock, shares issued (in Shares) | 60.5M shares | 44.3M shares | |
| Common Stock, shares outstanding (in Shares) | 60.5M shares | 44.3M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow in the latest annual report, as filed.3
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net Loss | -$1.8M | -$1.3M |
| Share-based compensation | $1.3M | $1.0M |
| Gain on settlement of accounts payable | -$3.8K | $0 |
| Loss on conversion of related party debt | $23.3K | $0 |
| Loss on conversion of mezzanine equity | $68.2K | $0 |
| Accounts receivable | $285 | -$285 |
| Inventory | $910 | $4.3K |
| Accounts payable and accrued expenses | $299.1K | $121.9K |
| Settlement payable | $0 | -$5.5K |
| Net Cash Used in Operating Activities | -$127.5K | -$110.6K |
| Proceeds from sale of common stock | $90.0K | $13.3K |
| Contributed capital - related party | $38.4K | $7.0K |
| Proceeds from convertible notes payable - related party | $0 | $51.0K |
| Proceeds from (repayments of) short-term loan - related party | -$1.5K | $1.5K |
| Net Cash Provided by Financing Activities | $126.9K | $72.8K |
| Net increase (decrease) in cash and cash equivalents | -$541 | -$37.8K |
| Cash paid for interest | $1.5K | $200 |
| Cash paid for taxes | $0 | $0 |
| Shares issued for conversion of convertible notes payable | $99.8K | $0 |
| Shares issued for conversion of accrued salaries | $211.0K | $0 |
| Shares issued for settlement of accounts payable | $57.0K | $0 |
| Shares issued for conversion of mezzanine equity | $37.9K | $0 |
| Cancellation of shares of common stock | $0 | $475 |
Recent filings
- Aug 12, 202610-Q
- May 11, 202610-Q
- Mar 23, 202610-K
- Nov 18, 202510-Q
- Nov 13, 2025NT 10-Q
- Sep 9, 202510-Q
- Aug 28, 20258-K
- Aug 15, 20254
- Aug 15, 20254
- Aug 15, 20254
- Aug 15, 20254
- Aug 15, 2025NT 10-Q
- Jul 21, 202510-Q
- May 16, 2025NT 10-Q
- May 12, 20258-K
Every filing from the last three years, summarized. The full record is on SEC EDGAR.1
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7